ESR1 and breast carcinoma: NR1C1 anti-tumor activity may be of particular relevance in ER+/breast-cancer, since anti-estrogens induce NR1C1-mRNA in ER+/MCF-7 cells and ERα over-expression into ER−/MDA-MB-231 cells decreases NR1C1-mRNA [11].